The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019


Awedew A. F., Han H., Abbasi B., Abbasi-Kangevari M., Ahmed M. B., Almidani O., ...More

LANCET HEALTHY LONGEVITY, vol.3, no.11, 2022 (ESCI, Scopus)

  • Publication Type: Article / Article
  • Volume: 3 Issue: 11
  • Publication Date: 2022
  • Doi Number: 10.1016/s2666-7568(22)00213-6
  • Journal Name: LANCET HEALTHY LONGEVITY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, Directory of Open Access Journals
  • Süleyman Demirel University Affiliated: Yes

Abstract

Background Benign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted life-years (DALYs) due to benign prostatic hyperplasia, in 21 regions and 204 countries and territories from 2000 to 2019.